‘Superglue’ Helps In Rapid Creation Of Robust & Novel Vaccines
Monday, April 3, 2017
SpyBiotech will utilize biochemical “superglue” to aid the rapid development of robust and novel vaccines. The company derived their name from “Streptococcus pyogenes” (Spy), the causative agent of a number of infections.
According to Phys Org, the team of researchers from SpyBiotech divided the Spy into a SpyTag (peptide) and SpyCatcher (protein partner). The two divisions of the Spy are naturally attracted to each other forming a covalent bond hence the term biochemical “superglue”.
SpyBiotech believes that the covalent bond created by SpyTag and SpyCatcher is needed in the effective development and production of highly effective vaccines. The biochemical “superglue” will target virus-like particles (VLPs), which is a leading technology in activating immune responses by vaccination. VLPs resemble viruses but do not cause any infections; instead, it is created with bug-busting antigens.
- Health Care